-
Emerging Role of BRAF Inhibitors in Relapsed/Refractory Hairy Cell Leukemia Treatment
24 Feb 2025 19:58 GMT
… , such as vemurafenib (Zelboraf; Genentech) and dabrafenib … , phase 2 clinical trial (NCT01711632) first evaluated … disease duration, treatment history, and medical history, demonstrated a … geted approach. Clinical trials assessing vemurafenib, dabrafenib, …
-
Dr Doonan on Treatment Strategies Following Progression on ICIs in Advanced Melanoma
12 Dec 2024 15:42 GMT
… , Department of Medicine, College of Medicine, the University … such as vemurafenib (Zelboraf) and dabrafenib (Tafinlar … access it, clinical trials and novel combination … drugs adapted from other cancer types, Doonan reports. Beyond these strategies, treatment …
-
Dr Truong on the Background of the ImmunoCobiVem Trial in BRAF V600+ Melanoma
07 Nov 2024 20:36 GMT
Thach-Giao Truong, MD, medical director, Melanoma Program, Cleveland … the targeted therapy combination vemurafenib (Zelboraf) and cobimetinib (Cotellic). Following … trials often did not investigate combined immunotherapy for melanoma treatment.
This trial …
-
Bumrungrad Health Briefs #42: Targeted Therapy: A Precision Approach to Cancer Treatment
25 Oct 2024 08:51 GMT
… Approach to Cancer Treatment
Cancer treatment is advancing rapidly … This form of precision medicine falls into three main … be treated with targeted drugs like erlotinib (Tarceva) … BRAF inhibitors like vemurafenib (Zelboraf).
These therapies have …
-
ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs
05 Aug 2024 20:15 GMT
… launches of new medicines including Imbruvica®, Zelboraf®, Pepaxto®, Posimir … About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical … - and immunotherapy-based treatment regimens, being developed … studies and clinical trials for, obtain approvals …
-
Advanced Melanoma Clinical Trial Pipeline Analysis Demonstrates 55+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
08 Jul 2024 17:00 GMT
… particularly immunotherapy medications. These medications have demonstrated … of Vemurafenib (Zelboraf), which effectively … melanoma treatment drugs @ Drugs for Advanced Melanoma Treatment … , Spring Bank Pharmaceuticals, Taiga Biotechnologies, Inc., Aivita …
-
Delhi Police busts international syndicate smuggling banned ‘life-saving’ cancer drugs
06 Jun 2024 12:33 GMT
… unregistered life-saving drugs, including anti-cancer medications, in Delhi and … Egypt to India.
The drugs smuggled included: Zelboraf 240 mg tablet, Opdivo … coordinated with drug department officials and employees of relevant pharmaceutical companies.
First …
-
January - March 2024 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
07 May 2024 07:45 GMT
…
Lybalvi (olanzapine and samidorphan)
Drug-drug interaction
FDA is evaluating the need for … regulatory action.
Tetracyclines
Fixed drug eruption
FDA is evaluating the need … need for regulatory action.
Zelboraf (vemurafenib)
Colitis
FDA is evaluating the need …
-
April - June 2024 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
10 Mar 2024 07:55 GMT
… )
Quviviq (daridorexant)
Paradoxical drug reaction
FDA is evaluating the need for … fumarate) inhalation aerosol
Drug ineffective
FDA is evaluating the need … (dabrafenib)
Zelboraf (vemurafenib)
Acute febrile neutrophilic dermatosis
FDA is evaluating the …
-
October - December 2023 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
04 Feb 2024 08:45 GMT
… that contribute to wrong drug errors
FDA is evaluating the need …
Braftovi (encorafenib)
Zelboraf (vemurafenib)
Haemophagocytic lymphohistiocytosis
FDA is evaluating the need … and simvastatin)
Zetia (ezetimibe)
Drug-induced liver injury
The “Postmarketing …
About
© 1995-2025